Browsing Category "News"

Our Postdoc trainee, Dr. Bo Li, joins the Loma Linda University as an Assistant Professor. Congratulations, Bo!

Dr. Lili Yang receives a $7.6M CIRM 2.0 Partnering Opportunity for Translational Research Projects Award to translate a new stem cell-based immunotherapy into clinics. [PDF][Link]

Our former Lab Manager, Claret Siyuan Liu, joins Amgen as a Scientist. Congratulations, Claret!

Our PhD Student, Drake Smith, receives a T32 Tumor Immunology Training Grant. Congratulations, Drake!

Drs. David Baltimore, Owen Witte, and Lili Yang jointly receive a $1M GTSN Challenge Award for Lethal Prostate Cancer from the Prostate Cancer Foundation (PCF), to study T cell receptor gene therapy for treatment of lethal prostate cancer.

Our PNAS paper on stem cell-engineering iNKT cells is listed as the TOP STORY on the Hematopoiesis News. [PDF][Link]

Our paper on stem cell-engineered invariant natural killer T (iNKT) cells is published online on PNAS. Congratulations to all the authors, in particular to the first author Drake Smith! [PDF][Link]

Dr. Lili Yang receives a $150,000 STOP CANCER Research Career Development Award to study tumor immunology and cancer immunotherapy. [PDF][Link]

Dr. Lili Yang receives a $2.3M NIH Director’s New Innovator (DP2) Award to develop new ways using blood stem cells to attack cancer. [PDF][Link]

Dr. Lili Yang receives a $50,000 Stem Cell Research Award from the Concern Foundation, to study stem cell-engineered iNKT cell therapy for breast cancer.